Extracorporeal membrane oxygenation in adults: a retrospective analysis of differences in indication, morbidity and mortality in a single-centre observational study.

Extracorporeal membrane oxygenation in adults: a retrospective analysis of differences in indication, morbidity and mortality in a single-centre observational study. - no acronym is used

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00014629

Enrollment

131

Registered

2018-04-20

Start date

2017-11-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporal membrane oxygenation R57.0 R57.2 J80

Interventions

Group 1: Study participants are patients with ARDS (=Acute Respiratory Distress Syndrome) (n=54). The duration of the ECMO (Extracorporal membrane oxygenation) therapy depends primarily on cardiovascu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ARDS (Acute Respiratory Distress Syndrome); cardiogenic shock; septic shock; retrospective analysis of all patients treated in the Asklepios Klinik Langen with ECMO from April 2011 til July 2016.

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

Measure	Time frame
mortality	—

Secondary

Measure	Time frame
Prognostic factors just before ECMO for mortality	—

Countries

Germany

Contacts

Public ContactAlexander Buia

Asklepios Klinik langen

a.buia@asklepios.com061039121309

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026